Delivery Order SPE2DR25D2013-SPE2DR26F5QNL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,624.15 to AmerisourceBergen Drug Corp for Briviact 75 mg tablets (60-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,857.36 to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count) on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,551.85 to AmerisourceBergen Drug Corp for the supply of Briviact 75 mg tablets (60-count units) on May 14, 2025, with completion targeted for May 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,743.11 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count) on November 14, 2025, with completion scheduled for November 17, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order supporting federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,004.05 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count units) on November 18, 2025, with completion expected by November 19, 2025. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a $2,786.04 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 100 mg, with an ultimate completion date of October 20, 2025. This is a firm fixed price, non-competitive delivery order that serves the federal medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, with extensive experience...
- The Defense Logistics Agency awarded a delivery order valued at $3,601.40 to AmerisourceBergen Drug Corp for Briviact 50mg tablets (60-count) on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,715.46 to AmerisourceBergen Drug Corp for the supply of Briviact 50 mg tablets (60-count units). The contract, which is not set-aside and utilizes firm fixed pricing, was awarded on November 3, 2025, with an ultimate completion date of November 4, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,869.09 to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Briviact 50 mg tablets (60-count). This competitively awarded, firm fixed-price contract requires delivery by November 18, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Briviact 50 mg tablets (60-count units) at a ceiling value of $1,055.99. This firm fixed price delivery order, with an ultimate completion date of November 7, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- SPE2DR25D2013Indefinite Delivery Contract
- SPE2DR25D2013-SPE2DR26F5QNLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,975.11 to AmerisourceBergen Drug Corp for the supply of Briviact 75 mg tablets (60-count units) on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements through competitive federal procurement processes, with delivery orders ranging from modest transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 11/18/25 |